Supramaximal high-intensity interval training improves heart rate variability in older adults: A randomized controlled trial
Abstract
Heart rate variability (HRV), a marker of cardiovascular health, declines with aging and physical inactivity. We compared the effects of supramaximal high-intensity interval training (HIT) with brief intervals and moderate-intensity training (MIT) on HRV in non-exercising older adults. Sixty-eight participants were randomized to 12 weeks of supervised cycling performed twice weekly: supramaximal HIT (10 × 6-s intervals) or MIT (3 × 8-min intervals), with training intensity individually prescribed and progressively increased over the intervention using external power output. HRV was assessed using time-domain indices (SDNN, RMSSD, and LnRMSSD) and resting heart rate from 5-min segments, derived from 10-min recordings collected in participants' homes on seven consecutive days at baseline and follow-up. Between-group differences in change favored supramaximal HIT for SDNN (5.4 ms [95% CI: 1.1-9.7]), RMSSD (3.5 ms [0.7-6.3]), and LnRMSSD (0.15 [0.01-0.28]). Within-group changes showed an increase in RMSSD in the HIT group (2.0 ms [0.1-4.0]) and a decrease in SDNN in the MIT group (-3.1 ms [-6.2 to -0.1]). Resting heart rate did not differ between groups. In conclusion, supramaximal HIT induced more favorable HRV adaptations than MIT in non-exercising older adults.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.